Taking into consideration the results obtained in this study, the two EVOO phenolic compounds used do not modify the metabolic profile in the experimental model of type 1 diabetes mellitus, therefore their use could be suggested as an adjunct to the main treatment (insulin, diet, physical exercise) in order to prevent the appearance and development of diabetic neuropathy. This evidence concerns the gene INS and diabetes mellitus.